Faculty Information - Hirata Kenshiro

Hirata Kenshiro

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Book and thesis
1.	2022/10	Papers	High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry. Therapeutic drug monitoring 44 (5),pp.633-640 (Co-authored)
2.	2022/08	Papers	Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin. ACS omega 7 (34),pp.29944-29951 (Co-authored)
3.	2022/04	Papers	Response to "iPTH is not a significant factor influencing the tacrolimus C/D ratio". Clinical and translational science 15 (4),pp.807-808 (Co-authored)
4.	2022/02	Papers	Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural-Chemical Investigation. ACS omega 7 (5),pp.4413-4419 (Co-authored)
5.	2021/11	Papers	The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients. Toxins 13 (11) (Co-authored)
6.	2021/09	Papers	Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease. Clinical and translational science 14 (5),pp.2034-2042 (Co-authored)
7.	2020/07	Papers	Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis. Biological & pharmaceutical bulletin 43 (10),pp.1583-1590 (Co-authored)
8.	2019/01	Papers	Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule. Biological & pharmaceutical bulletin 42 (5),pp.786-791 (Co-authored)
9.	2017/12	Papers	Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism. Biochemical pharmacology 145,pp.192-201 (Co-authored)
10.	2015/02	Papers	Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models. The Journal of pharmacology and experimental therapeutics 352 (2),pp.244-57 (Co-authored)
11.	2014/10	Papers	Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM. Therapeutic drug monitoring 36 (5),pp.553-5 (Co-authored)
12.	2010/07	Papers	Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics. Journal of controlled release : official journal of the Controlled Release Society 145 (1),pp.9-16 (Co-authored)
13.	2005/05	Papers	CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. Journal of biochemistry 137 (5),pp.607-16 (Co-authored)